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Abstract
 
T cell receptor (TCR) internalization by clathrin-coated vesicles after encounter with antigen
has been implicated in the regulation of T cell responses. We demonstrate that TCR internal-
ization after receptor engagement and TCR signaling involves inducible phosphorylation of
clathrin heavy chain (CHC) in both CD4
 
  
 
and CD8
 
  
 
human T cells. Studies with mutant Jurkat
T cells implicate the Src family kinase Lck as the responsible enzyme and its activity in this process
is influenced by the functional integrity of the downstream signaling molecule ZAP-70. CHC
phosphorylation positively correlates with ligand-induced TCR internalization in both CD4
 
 
 
and CD8
 
  
 
T cells, and CHC phosphorylation as a result of basal Lck activity is also implicated
in constitutive TCR endocytosis by CD4
 
  
 
T cells. Remarkably, irreversible CHC phosphory-
lation in the presence of pervanadate reduced both constitutive and ligand-induced TCR
internalization in CD4
 
  
 
T cells, and immunofluorescence studies revealed that this inhibition
affected the early stages of TCR endocytosis from the plasma membrane. Thus, we propose
that CHC phosphorylation and dephosphorylation are involved in TCR internalization and
that this is a regulatory mechanism linking TCR signaling to endocytosis.
Key words: T lymphocytes • endocytosis • signal transduction • Src family kinases • 
lymphocyte activation
 
Introduction
 
The interaction of the TCR with peptide–MHC complexes
on APCs plays a critical role in the development of an
immune response to a foreign antigen. The TCR is an oli-
gomeric complex composed of three functional units, the
antigen-binding 
 
  
 
and 
 
  
 
chains and the signal transducing
CD3 
 
 
 
, 
 
 
 
, and 
 
  
 
chains as well as the distinct TCR 
 
  
 
chain
(1). Before encounter with antigen, TCRs are continuously
internalized and recycled back to the cell surface (2–4).
Once the TCR engages a peptide–MHC complex on the
surface of an APC, the TCR undergoes down-modulation.
This process reflects a combination of receptor internalization,
recycling, and degradation and is regulated by signaling
through the TCR (5). Thus, TCR endocytosis influences at
least two functions during T cell activation (6). First, inter-
nalization of the TCR potentiates the activation signal by
translocating the receptor from the plasma membrane to
early endosomes enriched for additional signaling molecules
(7). Second, TCR down-modulation from the endosome
attenuates signaling through this receptor by targeting the
TCR to a lysosomal compartment for degradation (8–10).
Clathrin has been implicated in TCR internalization at the
plasma membrane (11, 12) and could also play a role in
TCR down-modulation from the endosome. Here we
investigate the relationship between TCR signaling and the
clathrin-mediated pathway of TCR internalization.
The major structural components of the clathrin-coated
vesicle (CCV) are two oligomeric molecules, clathrin and
adaptor proteins (13). Clathrin is composed of three 
 
 
 
192-kD
heavy chains bound to three 
 
 
 
25-kD light chains. Adaptor
proteins are heterotetramers of 
 
 
 
270 kD that recognize
signals in the cytoplasmic domain of receptors and direct
their sequestration into a CCV at the plasma membrane.
The CD3 
 
 
 
, 
 
 
 
, and 
 
  
 
chains and the TCR 
 
  
 
chain each
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contain one of three previously described adaptor-binding
motifs (14), and TCR engagement with antigen likely ex-
poses these motifs through phosphorylation allowing for
CCV sequestration and TCR internalization at the plasma
membrane (3). Clathrin has also recently been implicated
in the trafficking of receptors to lysosomes through its asso-
ciation with the adaptor protein Hrs on endosomal mem-
branes (15). Hrs recognizes ubiquitinated receptors and
because the TCR becomes ubiquitinated upon antigen
binding (16, 17), clathrin via its association with Hrs may
regulate TCR down-modulation from endosomes to lyso-
somes. TCR internalization in CCVs is likely regulated
first at the plasma membrane when signaling through the
TCR exposes the adaptor binding motif in the receptor, as
has been observed for epidermal growth factor receptor
(EGFR; 18) and CTLA-4 (19). Recent studies of the
EGFR and the B cell receptor (BCR) demonstrate that re-
ceptor signaling also modifies clathrin heavy chain (CHC)
by phosphorylation, which plays a role in the regulation of
clathrin-mediated endocytosis (20, 21). This signal-induced
clathrin modification is a critical step for regulation of
expression of these receptors and represents a second
mechanism by which receptor signaling influences receptor
down-modulation.
The TCR signaling cascade is well characterized, com-
plex, and implicated in TCR down-modulation. The initi-
ating event is the phosphorylation of the immunoreceptor
tyrosine-based activating motifs (ITAMs) located in each of
the CD3 
 
 
 
, 
 
 
 
, and 
 
  
 
chains and in the TCR 
 
  
 
chain by the
Src family protein tyrosine kinase Lck. Lck also phosphory-
lates the downstream Syk family protein tyrosine kinase
ZAP-70 (22). Upon activation, ZAP-70 not only binds to
the phosphorylated ITAMs in the CD3 and 
 
  
 
chains (23),
but also phosphorylates the linker associated with T cell ac-
tivation (LAT) transmembrane protein (24). LAT unites
the proximal signaling events after TCR engagement with
the activation of downstream molecules that ultimately
leads to T cell proliferation and the development of effec-
tor functions (25). This entire pathway has been associated
with TCR internalization by the observations that the in-
hibition or absence of Src family kinases prevents TCR en-
docytosis (26–29). Here we demonstrate that there is a link
between the TCR signaling cascade and TCR internaliza-
tion involving CHC phosphorylation. We further establish
that Lck is the active kinase in clathrin modification by
TCR signaling and we present evidence that the regulation
of clathrin phosphorylation correlates with the pattern of
TCR surface expression.
 
Materials and Methods
 
Cell Lines.
 
The acute human T cell leukemia line Jurkat and
its derivatives, J.Cam1 (30), J.Cam1-Lck (31), J45.01 (32), P116
(33), P116.c39 (33), and J.Cam2 (34), were cultured in RPMI
1640 supplemented with 10% FBS and 10 mM Hepes. The Jur-
kat derivative DK33 (33) was maintained in the above cul-
ture medium supplemented with 500 
 
 
 
g/ml G418. The P116,
P116.c39, and DK33 cell lines were obtained from R. Abraham
(The Burnham Institute, La Jolla, CA). The J45.01 cell line was
purchased from American Type Culture Collection.
 
CTL.
 
The EBV-specific CTL clone LYcl48 was obtained
from A. Rickinson (University of Birmingham, Birmingham,
UK) and was derived and grown as previously described (35). In
brief, PBMCs from an EBV
 
  
 
donor were cultured with 
 
 
 
-irra-
diated B95.8 EBV-transformed autologous lymphoblastoid cell
lines at a responder to stimulator ratio of 40:1. Clone LYcl48 was
derived from these activated populations by seeding in semisolid
agarose or by limiting dilution cloning and was maintained by
weekly stimulation with mitomycin C–treated (Sigma-Aldrich)
autologous EBV-transformed lymphoblastoid cell lines in RPMI
1640 supplemented with 10% FBS, 2 mM glutamine, 15 mM
Hepes, 1% human serum, 25% supernatant of the IL-2–produc-
ing MLA-144 cell line, and 50 U/ml rIL-2 (Sigma-Aldrich).
 
Antibodies and Inhibitors.
 
The mouse mAb specific for human
CD3 was anti-Leu4 (BD Biosciences). The mouse mAb specific
for the Jurkat TCR was C305 (36). The mouse mAbs specific for
CHC were X22 (37) and TD.1 (38). The mouse mAb 4G10,
specific for phosphotyrosines, was provided by A. DeFranco
(University of California San Francisco, San Francisco, CA). The
mouse mAb specific for human transferrin receptor (hTfR) was
from Molecular Probes. The mouse mAb specific for the His
 
6
 
tag was from BD Biosciences. The rabbit polyclonal antiserum
against the clathrin light chains was anti-consensus peptide (39).
For immunoblotting, the polyclonal anti–mouse or anti–rabbit
secondary antibodies conjugated to horseradish peroxidase were
from Zymed Laboratories. For FACS
 
®
 
, the FITC-conjugated
F(ab
 
 
 
)
 
2 
 
fragment of goat anti–mouse Ig was from DakoCytoma-
tion and the FITC-conjugated anti-CD3 mAb was from BD
Biosciences. For immunofluorescence, rhodamine-conjugated
goat anti–mouse IgM was from Jackson ImmunoResearch Labo-
ratories. The Src kinase inhibitor PP1 was from BIOMOL Re-
search Laboratories, Inc., and a 20-mM stock solution was pre-
pared in DMSO. The serine/threonine kinase inhibitor H7 was
also from BIOMOL Research Laboratories, Inc., and a 100-mM
stock solution was prepared in DMSO.
 
T Cell Activation and Receptor Internalization.
 
T cells were
washed twice with cold PBS and then incubated with 10 
 
 
 
g/ml
anti-CD3 Ab or 4 
 
 
 
g/ml anti-hTfR Ab at a concentration of
10
 
7 
 
cells/ml for 30 min on ice. In some assays, Jurkat T cells
were incubated with 6-
 
 
 
m diameter polystyrene latex micro-
spheres purchased from Polysciences Inc. and coated with anti-
CD3 Ab. The Ab was adsorbed to the beads as previously
described (40, 41) with slight modifications. In brief, 250 
 
 
 
g pu-
rified anti-CD3 Ab was incubated with 10
 
7 
 
polystyrene beads in
a final volume of 500 
 
 
 
l PBS for 2 h at room temperature and
then overnight at 4
 
 
 
C with constant rotation. An aliquot of 10
 
7
 
beads was incubated in a final volume of 500 
 
 
 
l PBS plus 1%
BSA under the same conditions. The beads were then washed
three times with cold PBS, resuspended at 10
 
8 
 
beads/ml in cold
PBS, and stored at 4
 
 
 
C. The microspheres were incubated with
Jurkat T cells at a 2:1 ratio. After stimulation, the cells were
washed twice with cold PBS, resuspended at 10
 
7 
 
cells/ml in cold
PBS, and incubated at 37
 
 
 
C for various periods of time. Inter-
nalization was stopped by incubating the cells on ice and adding
cold PBS. The cells were then collected for either FACS
 
® 
 
or im-
munoprecipitation. In some assays, Jurkat T cells were treated
with a final concentration of 100 
 
 
 
M pervanadate and then im-
mediately incubated at 37
 
 
 
C for various periods of time. Inter-
nalization was stopped and the cells were collected for either
FACS
 
® 
 
or immunoprecipitation. The pervanadate stock solution
was prepared by mixing 2.3 
 
 
 
l of 30% H
 
2
 
O
 
2 
 
(Sigma-Aldrich) 
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with 1 ml of 20 mM Na
 
3
 
VO
 
4 
 
and allowing the mixture to react
for 5 min at room temperature.
 
Immunoprecipitation and Western Blotting.
 
Cells were lysed on
ice for 30 min in buffer containing 0.5% Triton X-100, 500 mM
Tris-HCl, pH 7.2, 20 mM EDTA, 30 mM NaF, 5 mM sodium
orthovanadate, 30 mM sodium pyrophosphate decahydrate, and
the following protease inhibitors: 1 mM PMSF, 5 
 
 
 
g/ml aproti-
nin, 10 
 
 
 
g/ml leupeptin, and 10 
 
 
 
g/ml pepstatin A. For CHC
immunoprecipitation, protein G–sepharose (Amersham Biosci-
ences) precleared lysates were incubated with 5 
 
 
 
g/ml X22 mAb
for 1 h at 4
 
 
 
C and then precipitated with protein G for 1 h at
4
 
 
 
C. Precipitated proteins were resolved on an 8% SDS-PAGE
gel, transferred onto nitrocellulose membrane (Schleicher &
Schuell), and immunoblotted using Abs specific for phosphoty-
rosine (4G10) or CHC (TD.1), followed by incubation with an
anti–mouse secondary peroxidase-conjugated Ab. Blots were
visualized with enhanced chemiluminescence (Amersham Bio-
sciences). For quantification of band intensities, autoradiographs
were scanned and analyzed using NIH Image software.
 
In Vitro Phosphorylation of CHC.
 
Recombinant Lck, ZAP-70,
and LAT were from Upstate Biotechnology. 10 or 25 ng Lck or
ZAP-70 were incubated with 5 
 
 
 
g His
 
6
 
-tagged clathrin Hub frag-
ment (residues 1074–1675), clathrin light chain b, or LAT in 10
mM MnCl
 
2
 
, 10 mM MgCl
 
2
 
, 50 mM Tris, pH 8, 1 mM TCEP,
and 10 mM ATP for 20 min at room temperature. Clathrin Hub
and light chain were prepared as previously described (42). The
phosphorylation reaction was stopped by the addition of SDS-
PAGE sample buffer and boiled for 5 min. Proteins were resolved
on a 10% SDS-PAGE gel and transferred onto nitrocellulose
membrane. The extent of tyrosine phosphorylation was analyzed
by immunoblotting using mAb 4G10 as described above. Clathrin
Hub was immunoblotted using the His
 
6 
 
tag Ab followed by an
anti–mouse secondary peroxidase-conjugated Ab. Clathrin light
chains were immunoblotted using the anti-consensus peptide Ab
followed by an anti–rabbit secondary peroxidase-conjugated Ab.
 
Flow Cytometric Analysis.
 
After incubation with either anti-
CD3 Ab or anti-hTfR Ab as described above, Jurkat T cells and
derivatives, as well as the CTL clone LYcl48, were stained with
FITC-conjugated anti–mouse Ig secondary Ab for 30 min on ice.
T cells that were left untreated or incubated with pervanadate as
described above were stained with FITC-conjugated anti-CD3
mAb for 30 min on ice. Cells were washed three times with PBS
plus 1% BSA and then fixed in 1% paraformaldehyde. Flow cy-
tometry was performed on a FACScan™ and the data were ana-
lyzed with CELLQuest™ software (BD Biosciences).
 
Indirect Immunofluorescent Microscopy.
 
Jurkat T cells were
washed twice with cold PBS and then incubated with either
C305 supernatant or 50 
 
 
 
g/ml FITC-labeled transferrin (Molec-
ular Probes) at a concentration of 10
 
7 
 
cells/ml for 30 min on ice.
After stimulation, the cells were washed twice with cold PBS, re-
suspended at 10
 
7 
 
cells/ml in cold PBS in the presence or absence
of a final concentration of 100 
 
 
 
M pervanadate, and incubated at
37
 
 
 
C for various periods of time. Internalization was stopped by
incubating the cells on ice and adding cold PBS. The cells were
then fixed with 4% paraformaldehyde and plated on poly-
 
l
 
-lysine–treated (Sigma-Aldrich) coverslips. TCR was detected
using a rhodamine-conjugated anti–mouse IgM secondary Ab.
Cells were viewed using a DeltaVision Restoration Microscope,
and a single section through the middle of the cell is shown (see
Fig. 7). Images were processed using Adobe Photoshop software.
The percent internalization was quantified from 200 images of
cells for each treatment from three independent experiments.
 
Results
 
CHC Is Inducibly Phosphorylated in Activated T Cells.
 
The goal of this study was to investigate the molecular
mechanisms linking TCR signaling with receptor internal-
ization. Previous studies with the EGFR (20) and the BCR
(21) had demonstrated that CHC becomes inducibly phos-
phorylated upon ligand binding and we sought to deter-
mine if CHC was also phosphorylated in T cells upon
TCR engagement. The human CD4
 
  
 
T cell leukemia line
Jurkat was treated with soluble anti-CD3 Ab and the cells
were then incubated at 37
 
 
 
C to induce TCR activation
and internalization. CHC was immunoprecipitated and
levels of phosphorylation were measured by immunoblot-
ting with a phosphotyrosine-specific Ab. In unstimulated
Jurkat cells, no increase in the basal level of CHC phos-
phorylation was observed upon incubation at 37
 
 
 
C (Fig. 1
A). However, after 5 min of incubation, a noticeable in-
crease (approximately fourfold) in CHC phosphorylation
in activated Jurkat cells was detected above basal levels fol-
lowed by a decrease in the signal at 20 min (Fig. 1 A). To
more accurately mimic the activation of T cells in vivo, we
also stimulated Jurkat cells with cell-sized beads that had
been coated with anti-CD3 Ab. When Jurkat cells were in-
Figure 1. CHC phosphoryla-
tion in T cells after TCR engage-
ment. (A) Jurkat cells were un-
treated (UT) or treated with
anti-CD3 Ab at 4 C and incu-
bated at 37 C for 0–20 min.
CHC was immunoprecipitated
from lysates, resolved by gel elec-
trophoresis, and immunoblotted
with an Ab to phosphotyrosine.
Blots were stripped and reprobed
with an Ab to CHC. To measure
the extent of tyrosine phosphor-
ylation relative to the levels of CHC immunoprecipitated, immunoblot images were quantified using the NIH Image software and the ratio of phospho-
tyrosine to CHC signal was plotted. (B) Jurkat cells were untreated or treated with beads (Bds) alone and left at 4 C. Jurkat cells were also treated with
anti-CD3 Ab or beads coated with anti-Q3 Ab (CD3   Bds) at 4 C and incubated at 37 C for 10 min. CHC phosphorylation was assessed as described
above. (C) Jurkat cells or CTL clone LYcl48 was untreated or treated with anti-CD3 Ab at 4 C and incubated at 37 C for 10 min. CHC phosphorylation was
assessed as described above. Bars below each lane represent the average ratio obtained for each stimulation condition for three independent experiments. 
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cubated with uncoated beads, no increase in the basal level
of CHC phosphorylation was observed upon incubation at
37
 
 
 
C (not depicted). However, after 10 min of incubation
with coated beads at 37
 
 
 
C, a measurable increase in CHC
phosphorylation was detected above basal levels (Fig. 1 B).
These results demonstrate that CHC is phosphorylated in
an inducible manner upon T cell activation by both soluble
and bound ligands. Lastly, we examined CHC phosphory-
lation in nontransformed human CD8
 
  
 
peripheral T cells.
The CTL clone LYcl48 was treated with soluble anti-CD3
Ab and the cells were then incubated for 10 min at 37
 
 
 
C to
induce TCR activation and internalization. A measurable
increase in CHC phosphorylation was detected above basal
levels (Fig. 1 C). Thus, CHC phosphorylation occurs upon
T cell activation in both the transformed CD4
 
  
 
Jurkat T
cell line and normal human CD8
 
  
 
CTL.
 
Clathrin Phosphorylation Requires the Activity of a Src Family
Kinase.
 
The kinetics of CHC phosphorylation in acti-
vated T cells was slow compared with the total protein ty-
rosine phosphorylation in cell lysates (not depicted). This
delay suggested that other signaling events are initiated be-
fore CHC phosphorylation. We had previously found that
the activation of c-Src kinase or Lyn kinase, a Src kinase
family member, was required for CHC phosphorylation af-
ter EGFR and BCR stimulation, respectively (20, 21). To
address whether the activity of a Src family kinase was nec-
essary for CHC phosphorylation in activated T cells, we
treated Jurkat cells with various concentrations of the Src
family kinase inhibitor PP1 before stimulation with soluble
anti-CD3 Ab. At increasing concentrations of PP1, but not
the serine/threonine kinase inhibitor H7, the level of in-
ducible CHC phosphorylation was diminished (Fig. 2 A).
Additionally, in the presence of PP1, the basal level of
CHC phosphorylation in Jurkat cells before the induction
of TCR internalization was also decreased, suggesting that
basal Src family kinase activity was responsible for the basal
level of CHC phosphorylation observed. To confirm these
results, we examined CHC phosphorylation in J.Cam1 T
cells, a mutant derived from Jurkat lacking the Src family
kinase Lck (30, 31). In contrast to Jurkat cells, both basal
and inducible CHC phosphorylation were significantly re-
duced in J.Cam1 cells (Fig. 2 B). This diminution in CHC
phosphorylation was not the result of decreased TCR sur-
face expression on the J.Cam1 cells (30 and confirmed by
data not depicted). When J.Cam1 cells were reconstituted
with Lck (J.Cam1-Lck; 31), basal and inducible CHC
phosphorylation were restored after T cell activation (Fig. 2
B). Lck expression in the reconstituted J.Cam1 cells was
 
 
 
20% of the expression in Jurkat cells, thus accounting for
the lower levels of CHC phosphorylation in activated
J.Cam1-Lck cells (unpublished data). Because the protein
tyrosine phosphatase (PTP) CD45 induces Lck activity by
dephosphorylating a tyrosine residue in the negative reg-
ulatory site of this kinase (43–45), we examined CHC
phosphorylation in the CD45-deficient Jurkat T cell line,
J45.01, in which Lck activity is attenuated (32). CHC
phosphorylation was significantly reduced in J45.01 cells
compared with Jurkat cells after activation (Fig. 2 B). These
results indicate that the Src family kinase Lck plays a critical
role in CHC phosphorylation in activated Jurkat cells.
 
Proximal TCR Signaling Is Responsible for CHC Phosphory-
lation.
 
Because the induction of Lck activity after TCR
stimulation initiates the signaling cascade in T cells (22), we
next sought to determine the contribution of downstream
TCR signaling events to CHC phosphorylation. Inducible
CHC phosphorylation in response to anti-CD3 Ab treat-
ment was reduced in P116 T cells lacking ZAP-70, a Syk
family kinase activated by phosphorylation by Lck, and in
DK33 T cells containing kinase-dead ZAP-70 (Fig. 3 A;
reference 33). However, the reduction in basal and induc-
ible CHC phosphorylation was not as extensive as that ob-
served for the Lck-deficient J.Cam1 cells (Fig. 2 B). The
diminution in CHC phosphorylation was not the result of
decreased TCR surface expression on P116 or DK33 cells
(not depicted). When P116 cells were reconstituted with
ZAP-70 (P116.c39; reference 33), basal and inducible
CHC phosphorylation were restored after T cell activation
(Fig. 3 A). These results suggest that although ZAP-70
plays a role in CHC phosphorylation, its effects on these
processes might be secondary to the activity of Lck.
To further define the roles of Lck and ZAP-70 in CHC
phosphorylation, we incubated a recombinant fragment of
the CHC (Hub residues 1074–1675) with either purified
recombinant Lck or ZAP-70 in vitro and measured the ex-
tent of phosphorylation by immunoblotting with a phos-
Figure 2. Lck activity is required for CHC phosphorylation. (A) Jurkat
cells were pretreated with 1% DMSO or various micromolar concentrations
of either the serine/threonine kinase inhibitor H7 or the Src kinase inhibitor
PP1 in DMSO. Cells were then treated with anti-CD3 Ab in the continuous
presence of DMSO   inhibitors at 4 C and incubated at 37 C for 0 or
5 min. CHC phosphorylation was assessed as described in Fig. 1. The
results are representative of two independent experiments. (B) Wild-type
Jurkat cells and the indicated Jurkat mutants were untreated (UT) or
treated with anti-CD3 Ab at 4 C and incubated at 37 C for 0–20 min.
Cells tested were JCam.1 (Lck deficient), JCam.1-Lck (JCam.1 recon-
stituted with Lck), and J45.01 (CD45 deficient). CHC phosphorylation
was assessed as described in Fig. 1. The results are representative of five
independent experiments. 
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photyrosine-specific Ab. We chose to test this segment of
CHC because we had previously identified the site of
CHC phosphorylation upon EGFR stimulation as tyrosine
1477 (20), which lies in a conserved region compatible
with the Src family kinase consensus sequence (46). Lck
but not ZAP-70 phosphorylates Hub in vitro (Fig. 3 B).
However, recombinant ZAP-70 was capable of phosphor-
ylating its known in vivo substrate LAT. Furthermore,
clathrin light chain b that lacks a Src consensus sequence
(47) was not phosphorylated by Lck. These results demon-
strated that Lck but not ZAP-70 directly phosphorylates
CHC in vitro
 
.
 
 Thus, the in vivo role of ZAP-70 in CHC
phosphorylation after T cell activation must be due to its
interaction with Lck, perhaps by a feedback mechanism. As
a final confirmation of the importance of proximal TCR
signaling in CHC phosphorylation, we examined J.Cam2
T cells deficient in LAT, a transmembrane protein linking
proximal and distal TCR signaling events (34). In the ab-
sence of LAT, CHC was still inducibly phosphorylated in
J.Cam2 cells after activation (Fig. 3 C). Taken together, the
above data provide strong evidence that the phosphoryla-
tion of clathrin in activated Jurkat T cells is the result of
proximal TCR signaling events that occur upstream of the
molecule LAT and is most likely attributed to Lck.
 
Clathrin Phosphorylation Links Proximal TCR Signaling
Events to TCR Internalization. The implication of Src
family kinase activity, particularly that of Lck, in TCR in-
ternalization had previously been reported (26–29). By
FACS® analysis, we also observed a significant impairment
in the ability of the Lck-deficient J.Cam1 and the CD45-
deficient J45.01 cell lines to internalize their TCR after Ab
stimulation (Fig. 4 A). Reconstituting J.Cam1 cells with
Lck restored TCR internalization to levels achieved in Jur-
kat cells after activation. TCR internalization was also
slightly reduced in the ZAP-70–defective cell lines P116
and DK33 (Fig. 4 B), suggesting that ZAP-70 activity also
influences Lck activity with respect to TCR internaliza-
tion. These proximal TCR signaling events were influen-
tial for TCR internalization, but we detected no deficiency
in the ability of the Lck signaling mutants J.Cam1 or J45.01
(Fig. 4 C), or the ZAP-70 signaling mutants P116 or DK33
(Fig. 4 D) to internalize the transferrin receptor. These re-
sults support a positive correlation between CHC phos-
phorylation and TCR internalization.
Having demonstrated that CHC was phosphorylated
in the CD8  CTL clone LYcl48, we also investigated
whether phosphorylation correlated with TCR internaliza-
tion, as seen for CD4  Jurkat cells. By FACS® analysis, we
observed ligand-induced TCR endocytosis in LYcl48 after
stimulation with anti-CD3 Ab, although the internalization
of this receptor was not as robust as seen with Jurkat cells
(Fig. 5). Thus, stimulated Lck phosphorylation of CHC
during TCR engagement correlates with receptor endocy-
tosis in both CD4  and CD8  T cells. Previous studies had
demonstrated that before encounter with antigen, TCRs
are constitutively internalized and recycled back to the cell
surface (2–4). Next, we investigated whether basal levels of
Lck activity might be involved in constitutive TCR inter-
nalization. Jurkat cells, the Lck-deficient J.Cam1 cells, and
the LYcl48 CTL were incubated at 37 C and steady-state
levels of surface TCR were measured by FACS® using
FITC-conjugated anti-CD3 Ab. Reduction in these levels
Figure 3. Proximal TCR signaling is responsible for CHC phosphory-
lation. (A) Wild-type Jurkat cells and the indicated Jurkat mutants were
untreated (UT) or treated with anti-CD3 Ab at 4 C and incubated at
37 C for 0–20 min. Cells tested were P116 (ZAP-70 deficient), DK33
(ZAP-70 inactive), and P116.c39 (P116 reconstituted with ZAP-70).
CHC phosphorylation was assessed as described in Fig. 1. (B) A bacterially
expressed fragment of His6-tagged CHC Hub (residues 1074–1675) was
incubated with either recombinant Lck or recombinant ZAP-70 in the
presence of ATP for 20 min at room temperature. As controls, bacterially
expressed clathrin light chain b (LC) was incubated with Lck and recom-
binant LAT was incubated with ZAP-70 in the presence of ATP for 20
min at room temperature. The proteins were resolved by gel electro-
phoresis and immunoblotted with an Ab to phosphotyrosine (top). The
identical samples were resolved on a second gel and immunoblotted
with an Ab to the His6-tag (lanes 1–6) or to LC (lanes 7 and 8; bottom).
(C) Wild-type Jurkat and J.Cam2 (LAT deficient) cells were untreated
(UT) or treated with anti-CD3 Ab at 4 C and incubated at 37 C for 0–20
min. CHC phosphorylation was assessed as described in Fig. 1. In A, B,
and C, each set of results is representative of three independent experiments.Clathrin Phosphorylation during T Cell Receptor Internalization 986
relative to staining at 4 C was considered constitutive in-
ternalization. Interestingly, we only observed constitutive
TCR internalization in Jurkat cells, and for these cells, it
was completely abolished in the absence of Lck (Fig. 5 B).
These results suggest that CHC phosphorylation is in-
volved in both constitutive and ligand-induced TCR inter-
nalization and implicate Lck activity (basal or stimulated).
However, they also demonstrate that the TCR does not al-
ways display constitutive endocytosis, perhaps reflecting
differences between CD4  and CD8  T cells and/or levels
of basal Lck activity.
Pervanadate Alters the Kinetics of CHC Phosphorylation and
TCR Internalization. Our results so far have suggested a
positive correlation between CHC phosphorylation and
TCR internalization in T cells after Ab stimulation and in
constitutive endocytosis. To investigate the mechanistic
impact of CHC phosphorylation, we analyzed the effect of
treating Jurkat cells with the PTP inhibitor pervanadate.
Treatment of Jurkat cells with pervanadate has been docu-
mented to activate the signal transduction events usually
observed upon ligand binding, despite its inhibition of the
PTP CD45, which normally regulates Lck activity. This
has been attributed to a net accumulation of phosphate on
the tyrosine residue in the activation loop of Lck, bypassing
the need for dephosphorylating the negative regulatory site
of Lck (48). Even in the absence of TCR stimulation,
CHC became substantially phosphorylated in Jurkat cells
treated with concentrations of 10  M and greater of per-
vanadate (Fig. 6 A). However, the kinetics of this phos-
phorylation was significantly different from that observed
Figure 4. TCR but not trans-
ferrin receptor internalization is
reduced in cells deficient in CHC
phosphorylation. Wild-type Jur-
kat cells ( ) and the indicated
Jurkat mutants were treated at
4 C with anti-CD3 Ab (A and
B) or an Ab against hTfR (anti-
hTfR Ab; C and D), incubated
at 37 C for 0–30 min, and then
transferred to 4 C to stop receptor
internalization. In A and C, cells
tested were JCam.1 (Lck deficient;
 ), JCam.1-Lck (JCam.1 recon-
stituted with Lck;  ), and J45.01
(CD45 deficient;  ). In B and D,
cells tested were P116 (ZAP-70
deficient;   ), P116.c39 (P116
reconstituted with ZAP-70;  ),
and DK33 (ZAP-70 inactive;  ).
Cells were stained with a FITC-
conjugated F(ab )2  fragment of
goat anti–mouse Ig to detect Ab
remaining at the cell surface. The
percent internalization represents
the percentage of cells negative
for surface Ab by FACS® analysis
relative to staining at 4 C. The
mean percent internalization
from three independent experi-
ments is shown. Note that the
size of the symbols at some
points masks the error bars.
Figure 5. Ligand-induced and consti-
tutive TCR internalization in CD4  and
CD8  T cells. Jurkat cells (A), J.Cam1
(Lck deficient) cells (B), or CTL clone
LYcl48 (C) was untreated ( ) or treated
( ) with anti-CD3 Ab at 4 C, incu-
bated at 37 C for 0–30 min, and then
transferred to 4 C to stop receptor inter-
nalization. Untreated cells were stained
with an FITC-conjugated anti-CD3 Ab
to detect reduction of TCR on the cell
surface relative to the level at 4 C, reflecting constitutive internalization. Stimulated cells were stained with a FITC-conjugated F(ab )2 fragment of goat
anti–mouse Ig Ab to detect remaining stimulatory Ab at the cell surface. The percent internalization represents the percentage of cells negative for surface
Ab by FACS® analysis relative to staining at 4 C. The mean percent internalization from three independent experiments is shown. Note the different
scales in A, B, and C.Crotzer et al. 987
for Jurkat cells stimulated with Ab. Upon pervanadate
treatment, CHC phosphorylation continued to accumulate
through 20 min after incubation at 37 C, the latest time
point we evaluated. To examine the kinase involved in this
pervanadate-induced phosphorylation, we analyzed per-
vanadate effects on Lck-deficient J.Cam1 cells, in which
CHC phosphorylation is negligible after TCR stimulation
(Fig. 2). Although CHC was phosphorylated in J.Cam1
cells after 20 min of treatment with 100  M pervanadate,
the level of phosphorylation was reduced 15-fold com-
pared with that observed in pervanadate-treated wild-type
Jurkat cells (Fig. 6 B). These data suggest that pervanadate
treatment and TCR engagement both activate the same
signaling pathway leading to CHC phosphorylation and
that CHC phosphorylation in both of these instances in-
volves Lck activity.
Figure 6. Pervanadate affects
clathrin phosphorylation and TCR
internalization but not TfR internal-
ization. (A) Jurkat cells were untreated
(UT) or treated with anti-CD3 Ab
at 4 C or with various micromolar
concentrations of pervanadate and
incubated at 37 C for 0–20 min.
(B) J.Cam1 (Lck deficient) or Jurkat
cells were untreated (UT) or treated
with anti-CD3 Ab at 4 C or with
100  M pervanadate and incubated
at 37 C for 0–20 min. CHC phos-
phorylation was assessed as described
in Fig. 1. The results are representative
of three independent experiments.
(C) Jurkat cells were untreated (UT;
 ) or treated with 100 ( ), 10 ( ),
or 1  M ( ) pervanadate, incubated
at 37 C for 0–30 min, and then
transferred to 4 C to stop constitutive
receptor internalization. Cells were
stained with FITC-conjugated anti-
CD3 Ab to detect reduction of TCR
on the cell surface relative to the
level at 4 C, reflecting constitutive
internalization. The percent internalization represents the percentage of cells negative for surface receptor by FACS® analysis relative to staining at 4 C.
The mean percent internalization from three independent experiments is shown. (D) Jurkat cells were treated with anti-CD3 Ab at 4 C in the presence
( , solid lines) and absence ( , dashed lines) of 100  M pervanadate or with anti-hTfR Ab in the presence ( , solid lines) and absence ( , dashed lines)
of 100  M pervanadate. Cells were incubated at 37 C for 0–30 min, transferred to 4 C to stop receptor internalization, and then stained with FITC-
conjugated F(ab )2 fragment of goat anti–mouse Ig to detect Ab remaining at the cell surface. The percent internalization represents the percentage of
cells negative for surface Ab by FACS® analysis relative to staining at 4 C. The mean percent internalization from three independent experiments is
shown. Note the different scales in C and D.
Figure 7. Pervanadate affects
TCR internalization at the plasma
membrane. Jurkat cells were
treated with anti-TCR Ab (A–C)
or FITC-conjugated transferrin
(D–F) at 4 C and incubated at
37 C for 0, 2, or 5 min in the
presence or absence of 100  M
pervanadate. Anti-TCR Ab is
detected using a rhodamine-
conjugated anti–mouse IgM
secondary Ab. The nucleus is
stained with DAPI. The results
are representative of at least three
independent experiments and
numbers are provided in Results.
Bar, 5  m for all panels.Clathrin Phosphorylation during T Cell Receptor Internalization 988
Next, we investigated the effect of pervanadate on
TCR internalization. Jurkat cells were treated with vari-
ous concentrations of pervanadate, incubated at 37 C, and
steady-state levels of surface TCR were measured by
FACS® using FITC-conjugated anti-CD3 Ab. We ob-
served a decrease in constitutive TCR internalization in
Jurkat cells treated with 10 and 100  M pervanadate
(Fig. 6 C). We also examined the effect of pervanadate
on ligand-induced TCR internalization. For Jurkat cells
stimulated with anti-CD3 Ab in the presence of 100  M
pervanadate, we observed a reduction in TCR endocyto-
sis (Fig. 6 D). The effect of pervanadate on inducible
TCR internalization was equivalent to its effect on con-
stitutive uptake because both processes were reduced to
50% of their level in the absence of the drug. The effect
of pervanadate upon ligand-induced internalization was
observed for the TCR, but we detected no deficiency in
the ability of Jurkat cells treated with pervanadate to in-
ternalize the transferrin receptor (Fig. 6 D). We observed
similar results when we examined the effect of pervana-
date on ligand-induced TCR internalization by immuno-
fluorescent microscopy (Fig. 7). Upon stimulation of
Jurkat cells with anti-TCR Ab in the presence of 100  M
pervanadate, we observed a lack of TCR endocytosis in
41% of the cells (n   200 in each of three independent
experiments; Fig. 7 C). In Jurkat cells stimulated with
anti-TCR Ab in the absence of the drug, only 18% of the
cells showed no TCR endocytosis with 82% of the cells
internalizing this receptor (n   200 in each of three inde-
pendent experiments; Fig. 7 B). Again, the effect of
pervanadate upon ligand-induced internalization was
observed for the TCR, but Jurkat cells treated with per-
vanadate were capable of internalizing FITC-conjugated
transferrin to the same degree as untreated cells (Fig. 7, E
and F). Taken together, the above results further impli-
cate CHC phosphorylation in influencing the expression
of TCR on the surface of Jurkat cells. They also suggest
that although CHC phosphorylation is involved in TCR
internalization, its subsequent dephosphorylation must be
part of the mechanism for both constitutive and ligand-
induced internalization.
Discussion
In this study, we demonstrate that inducible CHC phos-
phorylation occurs as a result of TCR signaling after TCR
engagement in both CD4  and CD8  T cells. The Src
family kinase Lck is apparently responsible for CHC phos-
phorylation and its activity is influenced by the integrity of
the downstream signaling molecule ZAP-70. CHC phos-
phorylation positively correlates with ligand-induced TCR
internalization in both CD4  and CD8  T cells and with
constitutive TCR endocytosis in CD4  T cells. Pervana-
date treatment causing irreversible CHC phosphorylation
reduced both constitutive and ligand-induced TCR inter-
nalization in CD4  T cells, and this inhibition occurred at
the early stages of ligand-induced TCR endocytosis from
the plasma membrane. By correlation, these studies impli-
cate both CHC phosphorylation and dephosphorylation as
influential in TCR internalization pathways.
Receptor-mediated endocytosis can be regulated both by
modification of the cytoplasmic domains of internalized re-
ceptors and by receptor signaling effects on clathrin coat
components. For a number of receptors including EGFR
and CTLA-4, ligand binding causes tyrosine kinase activa-
tion, resulting in a structural change that exposes adaptor-
binding motifs in the cytoplasmic domain of the receptors
(18, 19). Furthermore, receptor signaling induces the modi-
fication of trafficking proteins, in particular the phosphory-
lation of the CHC (20, 21). It has been proposed that upon
TCR engagement, the phosphorylation of the ITAMs
within the cytoplasmic domains of the TCR–CD3 complex
induces a conformational change exposing adaptor-binding
motifs allowing for the assembly of the CCV and TCR in-
ternalization (10, 28). Here we demonstrate that TCR sig-
naling also induces CHC phosphorylation in activated
CD4  and CD8  T cells. Similar to the EGFR and the
BCR (20, 21), CHC phosphorylation upon TCR engage-
ment is mediated by a Src family protein tyrosine kinase.
Our results indicate that the Src family kinase Lck directly
phosphorylates CHC in vitro, and in Jurkat cells deficient in
Lck, inducible CHC phosphorylation is abolished. Al-
though Lck plays a critical role in CHC phosphorylation,
we demonstrate that its activity is influenced by the integrity
of the proximal TCR signaling cascade. The reduction in
CHC phosphorylation observed in Jurkat T cells defective
in the downstream kinase ZAP-70 suggests that the activa-
tion of this kinase positively regulates Lck activity, thus ex-
plaining its influence on CHC phosphorylation and correla-
tion of ZAP-70 activity with TCR internalization.
In this study, we demonstrate a correlation between
CHC phosphorylation by Lck and TCR internalization af-
ter activation of both CD4  and CD8  T cells by receptor
engagement. Our data also suggest that basal Lck activity
plays a role in constitutive TCR internalization. Interest-
ingly, the CD8  CTL clone we examined here exhibited
very minimal constitutive TCR internalization, and its
ligand-induced TCR endocytosis was significantly less than
the CD4  Jurkat cells despite having higher overall levels of
the receptor on its surface. Recently, constitutive versus
ligand-induced TCR down-modulation has been evalu-
ated in murine CD4  T cells (10), but our study is the first
to examine these processes in a human CD8  CTL clone.
Although our findings may simply reflect intrinsic differ-
ences in normal versus transformed cells, we speculate
that the discrepancies in constitutive versus ligand-induced
TCR internalization in the CD4  and CD8  T cells might
be attributed to the different specialized functions of these
cells in vivo.
Previously, the site of clathrin phosphorylation upon
EGFR signaling was mapped to a single tyrosine residue at
amino acid position 1477 (20) in the region of the heavy
chain that interacts with light chain and regulates assembly
of the clathrin triskelion (38). Our preliminary studies sug-Crotzer et al. 989
gest that this tyrosine is also a target for Lck phosphor-
ylation of CHC as well as adjacent tyrosine residues
(unpublished data). It has been proposed that CHC phos-
phorylation could act either as a positive or a negative reg-
ulatory signal for clathrin function. For example, BCR sig-
naling activates the Src family kinase Lyn necessary for
CHC phosphorylation. This phosphorylation was shown
to correlate with BCR internalization after signaling in
rafts. The effect of CHC phosphorylation was compatible
with positive stimulation of assembly of clathrin associated
with rafts. It was, however, also compatible with a “nega-
tive” stabilization of preformed coated pits. In this latter
scenario, phosphorylation might delay interactions with
regulatory proteins required for the pit to vesicle transition
to capture spent signaling receptors from rafts (21). In this
study, we report the first data suggesting that CHC phos-
phorylation may indeed serve as a negative regulatory sig-
nal for CCV formation. Although our data show that CHC
phosphorylation correlates with TCR internalization, we
also demonstrate in experiments with pervanadate that if
CHC dephosphorylation cannot occur, both constitutive
and ligand-induced TCR internalization are reduced. This
inhibition of TCR internalization occurs at the plasma
membrane, reducing access of the TCR to early endo-
somes. Although pervanadate has pleiotropic effects on
cells, we found that CHC phosphorylation in the Lck-defi-
cient Jurkat cells treated with pervanadate was significantly
reduced compared with wild-type Jurkat cells, suggesting
that CHC phosphorylation after either pervanadate treat-
ment or TCR engagement involves Lck activity. Further-
more, we demonstrated that the internalization of the
transferrin receptor was not inhibited by pervanadate treat-
ment, thus eliminating the possibility of pleiotropic effects
of this drug on factors that affect endocytosis in general.
Thus, we propose that CHC phosphorylation and dephos-
phorylation are relevant to signaling receptors whose inter-
nalization is induced by ligand but not those that are con-
stitutively internalized.
Similar to its proposed role in BCR endocytosis, CHC
phosphorylation could influence clathrin function during
the initial TCR internalization from the plasma membrane
once the receptors have completed their signaling in rafts.
However, considering what is known about TCR path-
ways of down-modulation, it is also possible that CHC
phosphorylation plays a role in the regulation of receptor
levels at an additional intracellular site. Before encounter
with antigen, TCRs are continuously internalized and re-
cycled back to the cell surface (2–4). After TCR engage-
ment with antigen, the TCR is internalized and trafficked
to the lysosome for degradation (8–10). Clathrin is in-
volved in targeting receptors destined for degradation from
the endosome to lysosomes, and this pathway involves both
ubiquitination of receptors and the adaptor molecule Hrs
that interacts with ubiquitin and clathrin (15). CHC phos-
phorylation could be active during both internalization
from the plasma membrane and in diversion from endo-
somes to lysosomes. Further analysis will be required to es-
tablish how this modification of CHC influences CHC-
interacting proteins and affects either or both of these two
clathrin-mediated pathways.
Recent studies have established the importance of TCR
signaling (for review see reference 49) and TCR down-
modulation (50) at the contact site between T cells and
APCs, termed the immunological synapse. TCR down-
modulation at this synapse serves two purposes. Internaliza-
tion of the TCR from the plasma membrane to the endo-
some potentiates T cell activation by bringing the receptor
in close proximity to critical molecules required for pro-
gression of the TCR signaling cascade (7). The ultimate re-
sult of these signaling events is the complete activation of
the T cell and the development of an effective T cell re-
sponse to pathogenic organisms, tumors, or self-ligands in
cases of selection and autoimmunity. Second, TCR down-
modulation attenuates signaling by targeting the TCR
from the endosome to a lysosomal compartment for degra-
dation (8–10). This process maintains a homeostatic bal-
ance between activation and down-modulation of the T
cell response and may also function as a mechanism by
which tumors induce lack of detection by the immune sys-
tem (51). Clathrin has been implicated in both of these reg-
ulatory steps, and here we demonstrate that TCR signaling
can influence clathrin modification after T cell activation
through phosphorylation and dephosphorylation. We pro-
pose that this modification plays a role in both the develop-
ment and the modulation of the T cell response.
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